Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    CHROMOSOME 22q13.3 DELETION SYNDROME
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Conditions: 22q13 Deletion Syndrome;   Phelan-McDermid Syndrome
Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1);   Drug: Normal saline
2 Recruiting Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Intervention:

Indicates status has not been verified in more than two years